SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1um4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA302_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	4 / 6	LEU H 195 GLY H 196 ALA H 131 PRO H 132	None	0.51A	3huoA-1um4H: undetectable	3huoA-1um4H: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_A_CELA682_2 (PROSTAGLANDIN G/H SYNTHASE 2)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	4 / 8	LEU H 87 SER H 86 LEU H 82 TYR H 95	None	0.75A	3ln1A-1um4H: undetectable	3ln1A-1um4H: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKK_A_SUZA201_1 (TRANSTHYRETIN)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	4 / 8	LEU H 130 ALA H 143 SER H 133 SER H 134	None	0.97A	4ikkA-1um4H: undetectable 4ikkB-1um4H: undetectable	4ikkA-1um4H: 21.86 4ikkB-1um4H: 21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.83A	4qvnH-1um4H: undetectable 4qvnI-1um4H: undetectable	4qvnH-1um4H: 22.45 4qvnI-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 10	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.83A	4qvnV-1um4H: undetectable 4qvnW-1um4H: undetectable	4qvnV-1um4H: 22.45 4qvnW-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.80A	4qvpH-1um4H: undetectable 4qvpI-1um4H: undetectable	4qvpH-1um4H: 22.45 4qvpI-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.80A	4qvpV-1um4H: undetectable 4qvpW-1um4H: undetectable	4qvpV-1um4H: 22.45 4qvpW-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.82A	4qvqH-1um4H: undetectable 4qvqI-1um4H: undetectable	4qvqH-1um4H: 22.45 4qvqI-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.81A	4qvqV-1um4H: undetectable 4qvqW-1um4H: 0.0	4qvqV-1um4H: 22.45 4qvqW-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.85A	4qvvH-1um4H: undetectable	4qvvH-1um4H: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.85A	4qvvV-1um4H: undetectable	4qvvV-1um4H: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qvyH-1um4H: undetectable	4qvyH-1um4H: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qvyV-1um4H: undetectable 4qvyW-1um4H: undetectable	4qvyV-1um4H: 22.45 4qvyW-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qw0H-1um4H: undetectable 4qw0I-1um4H: undetectable	4qw0H-1um4H: 22.45 4qw0I-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qw0V-1um4H: undetectable 4qw0W-1um4H: undetectable	4qw0V-1um4H: 22.45 4qw0W-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qw1H-1um4H: undetectable 4qw1I-1um4H: undetectable	4qw1H-1um4H: 22.45 4qw1I-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qw1V-1um4H: undetectable 4qw1W-1um4H: undetectable	4qw1V-1um4H: 22.45 4qw1W-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qwuH-1um4H: undetectable 4qwuI-1um4H: undetectable	4qwuH-1um4H: 22.45 4qwuI-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.84A	4qwuV-1um4H: undetectable 4qwuW-1um4H: undetectable	4qwuV-1um4H: 22.45 4qwuW-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.85A	5bxnH-1um4H: undetectable 5bxnI-1um4H: undetectable	5bxnH-1um4H: 20.75 5bxnI-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_H_SAMH301_1 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	4 / 5	THR H 88 GLY H 16 GLU H 83 ASP H 91	None	1.26A	5c0oH-1um4H: undetectable	5c0oH-1um4H: 19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.83A	5cz7V-1um4H: undetectable 5cz7W-1um4H: undetectable	5cz7V-1um4H: 22.45 5cz7W-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 11	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.83A	5d0xV-1um4H: undetectable	5d0xV-1um4H: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERS_A_ACTA803_0 (GEPHYRIN)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	3 / 3	THR H 29 ALA H 25 ASN H 78	None	0.63A	5ersA-1um4H: undetectable	5ersA-1um4H: 19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.79A	5l5fH-1um4H: undetectable 5l5fI-1um4H: undetectable	5l5fH-1um4H: 22.45 5l5fI-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.79A	5l5fV-1um4H: undetectable 5l5fW-1um4H: undetectable	5l5fV-1um4H: 22.45 5l5fW-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.83A	5l66H-1um4H: undetectable 5l66I-1um4H: undetectable	5l66H-1um4H: 22.45 5l66I-1um4H: 24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.83A	5l66V-1um4H: undetectable 5l66W-1um4H: undetectable	5l66V-1um4H: 22.45 5l66W-1um4H: 24.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MTH_A_ACTA302_0 (ANTIBODY FAB HEAVY CHAIN)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	4 / 5	SER H 118 ALA H 120 PHE H 152 LEU H 176	None	0.41A	5mthA-1um4H: 27.1	5mthA-1um4H: 67.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1um4	ANTIBODY 21H3 H CHAIN (Mus musculus)	5 / 12	SER H 194 GLY H 140 THR H 141 ALA H 142 THR H 137	None	0.93A	6hwdH-1um4H: undetectable 6hwdI-1um4H: undetectable	6hwdH-1um4H: 19.69 6hwdI-1um4H: 23.97

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["3HUO_A_PNNA302_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",4,"LEU H 195;GLY H 196;ALA H 131;PRO H 132","None","0.51A","3huoA-1um4H:undetectable","3huoA-1um4H:23.81"],["3LN1_A_CELA682_2","PROSTAGLANDIN G\/H SYNTHASE 2","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",4,"LEU H  87;SER H  86;LEU H  82;TYR H  95","None","0.75A","3ln1A-1um4H:undetectable","3ln1A-1um4H:16.58"],["4IKK_A_SUZA201_1","TRANSTHYRETIN;TRANSTHYRETIN","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",4,"LEU H 130;ALA H 143;SER H 133;SER H 134","None","0.97A","4ikkA-1um4H:undetectable;4ikkB-1um4H:undetectable","4ikkA-1um4H:21.86;4ikkB-1um4H:21.86"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.83A","4qvnH-1um4H:undetectable;4qvnI-1um4H:undetectable","4qvnH-1um4H:22.45;4qvnI-1um4H:24.79"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.83A","4qvnV-1um4H:undetectable;4qvnW-1um4H:undetectable","4qvnV-1um4H:22.45;4qvnW-1um4H:24.79"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.80A","4qvpH-1um4H:undetectable;4qvpI-1um4H:undetectable","4qvpH-1um4H:22.45;4qvpI-1um4H:24.79"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.80A","4qvpV-1um4H:undetectable;4qvpW-1um4H:undetectable","4qvpV-1um4H:22.45;4qvpW-1um4H:24.79"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.82A","4qvqH-1um4H:undetectable;4qvqI-1um4H:undetectable","4qvqH-1um4H:22.45;4qvqI-1um4H:24.79"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.81A","4qvqV-1um4H:undetectable;4qvqW-1um4H:0.0","4qvqV-1um4H:22.45;4qvqW-1um4H:24.79"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.85A","4qvvH-1um4H:undetectable","4qvvH-1um4H:22.45"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.85A","4qvvV-1um4H:undetectable","4qvvV-1um4H:22.45"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qvyH-1um4H:undetectable","4qvyH-1um4H:22.45"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qvyV-1um4H:undetectable;4qvyW-1um4H:undetectable","4qvyV-1um4H:22.45;4qvyW-1um4H:24.79"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qw0H-1um4H:undetectable;4qw0I-1um4H:undetectable","4qw0H-1um4H:22.45;4qw0I-1um4H:24.79"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qw0V-1um4H:undetectable;4qw0W-1um4H:undetectable","4qw0V-1um4H:22.45;4qw0W-1um4H:24.79"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qw1H-1um4H:undetectable;4qw1I-1um4H:undetectable","4qw1H-1um4H:22.45;4qw1I-1um4H:24.79"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qw1V-1um4H:undetectable;4qw1W-1um4H:undetectable","4qw1V-1um4H:22.45;4qw1W-1um4H:24.79"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qwuH-1um4H:undetectable;4qwuI-1um4H:undetectable","4qwuH-1um4H:22.45;4qwuI-1um4H:24.79"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.84A","4qwuV-1um4H:undetectable;4qwuW-1um4H:undetectable","4qwuV-1um4H:22.45;4qwuW-1um4H:24.79"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.85A","5bxnH-1um4H:undetectable;5bxnI-1um4H:undetectable","5bxnH-1um4H:20.75;5bxnI-1um4H:24.79"],["5C0O_H_SAMH301_1","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",4,"THR H  88;GLY H  16;GLU H  83;ASP H  91","None","1.26A","5c0oH-1um4H:undetectable","5c0oH-1um4H:19.71"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.83A","5cz7V-1um4H:undetectable;5cz7W-1um4H:undetectable","5cz7V-1um4H:22.45;5cz7W-1um4H:24.79"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.83A","5d0xV-1um4H:undetectable","5d0xV-1um4H:22.45"],["5ERS_A_ACTA803_0","GEPHYRIN","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",3,"THR H  29;ALA H  25;ASN H  78","None","0.63A","5ersA-1um4H:undetectable","5ersA-1um4H:19.06"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.79A","5l5fH-1um4H:undetectable;5l5fI-1um4H:undetectable","5l5fH-1um4H:22.45;5l5fI-1um4H:24.79"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.79A","5l5fV-1um4H:undetectable;5l5fW-1um4H:undetectable","5l5fV-1um4H:22.45;5l5fW-1um4H:24.79"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.83A","5l66H-1um4H:undetectable;5l66I-1um4H:undetectable","5l66H-1um4H:22.45;5l66I-1um4H:24.79"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.83A","5l66V-1um4H:undetectable;5l66W-1um4H:undetectable","5l66V-1um4H:22.45;5l66W-1um4H:24.79"],["5MTH_A_ACTA302_0","ANTIBODY FAB HEAVY CHAIN","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",4,"SER H 118;ALA H 120;PHE H 152;LEU H 176","None","0.41A","5mthA-1um4H:27.1","5mthA-1um4H:67.58"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1um4","ANTIBODY 21H3 H CHAIN","Mus musculus",5,"SER H 194;GLY H 140;THR H 141;ALA H 142;THR H 137","None","0.93A","6hwdH-1um4H:undetectable;6hwdI-1um4H:undetectable","6hwdH-1um4H:19.69;6hwdI-1um4H:23.97"]]